Several studies reported that blocking IL-6 with anti-IL-6 antibodies or knockout of IL-6 significantly improved survival and delayed nephritis [37–39], whereas mice with IL-6 over-expression developed mesangial proliferative glomerulonephritis [40, 41]. The gene discussed is IL6; the disease is nephritis.